Per Samuelsson - Profile and Investment Details

Investor Profile

Per Samuelsson is a Venture Capital, Private Equity Firm, Investor based in Sweden with a diverse investment portfolio that includes companies such as Priothera, Spruce Biosciences, BONESUPPORT, Arpida AG, Renovis, Aprea, Immune Targeting SystemsGlionova, LTB4 Sweden, ChemoCentryx, Oncos Therapeutics, Gyros, PTC Therapeutics, Precirix, Renovo, Hybrigenics, GenSight Biologics, OraPharma Inc. (acquired by JNJ), Pulmonx, Cardoz, Biolipox, InCarda Therapeutics, Jerini, Orexo, Nexstim, Five Prime Therapeutics, BeneChill, Modus Therapeutics, Wilson Therapeutics, Algeta, BioStratum, Alba Therapeutics, Aro Biotherapeutics, Carisma Therapeutics, Actelion Pharmaceuticals, Idea, Pharmion, Strongbridge Biopharma, CoreValve, Dynavax Technologies, SpineVision, Ultragenyx Pharmaceutical, FerroKin Biosciences, Resistentia Pharmaceuticals, Cytos, Doctrin, Rainier Therapeutics, Sopherion Therapeutics, Richard Hägglöf Fondkommission, Lumavita, Oncorena, Tisbury Pharmaceuticals, Nucleonics, Vivet Therapeutics, Altimmune, Fusion Pharmaceuticals, ABB Aros Securites, Bionaut Pharmaceuticals, OxThera, Tengion, . Over time, Per Samuelsson has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Per Samuelsson is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Drug Discovery, Wellness, Women Founded, Rare Diseases, Healthcare Innovation, Life Science, Portfolio Management, Medical Technologies, Finance, Software, Biotechnology, Medical Devices, Precision Medicine, Clinical Trials, Gene Therapy, Personalized Medicine, Health Diagnostics, Digital Health, Medical, Information Technology, B2B, Therapeutics, Pharmaceuticals, Service Industry, Healthcare Technology, Oncology may find it worthwhile to explore potential connections with Per Samuelsson, as their portfolio suggests a familiarity and interest in this area.

Understanding Per Samuelsson’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.